FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease CNBCWith expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK's Arexvy. But will it amount to much? FiercePharmaHealthCentral: Which RSV Vaccine Is Right for You? Cedars-SinaiGSK's Arexvy Vaccine Shows Strong Efficacy Against RSV in Older Adults AJMC.com Managed Markets Network

BING NEWS:
  • Pfiz­er wins ap­proval to ex­pand RSV vac­cine to adults at high­er in­fec­tion risk
    Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval this week. The shot, Abrysvo, is ...
    10/23/2024 - 8:26 am | View Link
  • FDA Approves RSV Vaccine
    Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...
    10/23/2024 - 6:41 am | View Link
  • FDA Approves Abrysvo RSV Vaccine for Adults at Increased Risk
    Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.
    10/23/2024 - 5:45 am | View Link
  • FDA expands Pfizer’s RSV vaccine label to include all high-risk adults
    Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults aged over 18 years.
    10/23/2024 - 5:31 am | View Link
  • Pfizer’s RSV vaccine cleared by FDA for use in some younger adults
    Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people eligible for vaccination with the shot.
    10/23/2024 - 5:04 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News